Your browser doesn't support javascript.
loading
TP53 mutation, mitochondria and cancer.
Kamp, William M; Wang, Ping-Yuan; Hwang, Paul M.
Afiliação
  • Kamp WM; Center for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wang PY; Center for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Hwang PM; Center for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: hwangp@mail.nih.gov.
Curr Opin Genet Dev ; 38: 16-22, 2016 06.
Article em En | MEDLINE | ID: mdl-27003724
ABSTRACT
Under normal conditions, basal levels of wild-type p53 promote mitochondrial function through multiple mechanisms. Remarkably, some missense mutations of p53, in contrast to the null state, can result in the retention of its metabolic activities. These effects are particularly prominent in the mitochondria and demonstrate a functional role for mutant p53 in cancer metabolism. This review summarizes accumulating data on the mechanisms by which p53 missense mutations can regulate mitochondrial metabolism and promote the viability and survival of both normal and cancer cells, thus acting as a double edged sword for the host. Greater understanding of these mechanisms may provide insights for developing new treatment or preventive strategies against cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Mitocôndrias / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Mitocôndrias / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article